Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry have?
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry has 104 citations in the OpenAlex counts ScholarIQ stores.
When was Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry published?
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry has 2021 year in the ScholarIQ index.
What is the open-access status of Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry?
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry has bronze oa status in the ScholarIQ index.
What is the DOI of Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry?
The DOI for Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry is on the source record.
What is the PMID of Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry?
The PMID for Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry is on the source record.
What is the OpenAlex record for Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry?
The OpenAlex for Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry is on the source record.